Search Results - "Holmøy, T."

Serum sickness following rituximab therapy in multiple sclerosis by Holmøy, Trygve, Fogdell-Hahn, Anna, Svenningsson, Anders

Get full text

Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications? by Kampman, M. T., Eriksen, E. F., Holmøy, T.

“…Kampman MT, Eriksen EF, Holmøy T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?
Acta…”
Get full text

Uncovering health and social care needs among myotonic dystrophy patients by Holmøy, Anne Katrin T., Johannessen, Cecilie Haggag, Hope, Sigrun, van Walsem, Marleen R., Aanonsen, Nils Olav, Hassel, Bjørnar

“…Objectives Myotonic dystrophy type 1 (DM1) is a slowly progressive multisystem disorder. Guidelines recommend multidisciplinary follow‐up. We aimed to…”
Get full text

The immunology of multiple sclerosis: disease mechanisms and therapeutic targets by Holmøy, T

“…The disease mechanism of multiple sclerosis (MS) involves inflammation, demyelination and neurodegeneration. The relation between these components is not…”
Get more information

The Immunological Basis for Treatment of Multiple Sclerosis by Holmøy, T., Vartdal, F.

“…During the last few years, the concept of multiple sclerosis (MS) as a pure inflammatory disease mediated by myelin reactive T cells has been challenged…”
Get full text

T cells in amyotrophic lateral sclerosis by Holmøy, T.

“…The inflammatory process in ALS involves infiltration of T cells and activation of antigen presenting cells co‐localizing with motor neuron damage in the brain…”
Get full text

Fat-soluble vitamins as disease modulators in multiple sclerosis by Torkildsen, Ø., Løken-Amsrud, K. I., Wergeland, S., Myhr, K.-M., Holmøy, T.

Get full text

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients by Wergeland, S., Myhr, K.-M., Løken-Amsrud, K. I., Beiske, A. G., Bjerve, K. S., Hovdal, H., Midgard, R., Kvistad, S. S., Holmøy, T., Riise, T., Torkildsen, Ø.

“…Background and purpose Our objective was to study the association between serum levels of anti Epstein–Barr virus nuclear antigen 1 (EBNA‐1) antibody and…”
Get full text

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells by Berge, T, Leikfoss, I S, Brorson, I S, Bos, S D, Page, C M, Gustavsen, M W, Bjølgerud, A, Holmøy, T, Celius, E G, Damoiseaux, J, Smolders, J, Harbo, H F, Spurkland, A

“…Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system that develops in genetically susceptible individuals. The…”
Get full text

Approach to bone protection in multiple sclerosis by McKenna, M. J., Holmøy, T.

“…Click here to view the accompanying paper in this issue…”
Get full text

T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid by Holmøy, T, Vandvik, B, Vartdal, F

“…Idiotopic sequences are created after V, D and J recombinations and by somatic mutations during affinity maturation of immuglobulin (Ig) molecules, and may…”
Get full text

Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome by MOEN, S. M, CELIUS, E. G, SANDVIK, L, NORDSLETTEN, L, ERIKSEN, E. F, HOLMØY, T

“…Osteoporosis is common in patients with multiple sclerosis (MS) with long-standing disease. Hypovitaminosis D is a candidate risk factor for MS, and vitamin D…”
Get full text

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial by Storm-Larsen, C, Myhr, K-M, Farbu, E, Midgard, R, Nyquist, K, Broch, L, Berg-Hansen, P, Buness, A, Holm, K, Ueland, T, Fallang, L-E, Burum-Auensen, E, Hov, JR, Holmøy, T

“…Introduction Patients with multiple sclerosis may have a distinct gut microbiota profile. Delayed-release dimethyl fumarate is an orally administered drug for…”
Get full text

A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q) by Pugliatti, M., Casetta, I., Drulovic, J., Granieri, E., Holmøy, T., Kampman, M. T., Landtblom, A.-M., Lauer, K., Myhr, K.-M., Parpinel, M., Pekmezovic, T., Riise, T., Zhu, B., Wolfson, C.

“…Objectives The increasing incidence of multiple sclerosis (MS) worldwide, especially in women, points to the crucial role of environmental and lifestyle risk…”
Get full text

Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis by Hartung, H-P, Berger, T, Bermel, RA, Brochet, B, Carroll, WM, Holmøy, T, Karabudak, R, Killestein, J, Nos, C, Patti, F, Ross, A Perrin, Vanopdenbosch, L, Vollmer, T, Buffels, R, Garas, M, Kadner, K, Manfrini, M, Wang, Q, Freedman, MS

“…•Infusion-related reaction rates were similar in shorter and conventional infusions•The majority of infusion-related reactions were mild to moderate•No…”
Get full text

Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis by Moen, S. M., Celius, E. G., Nordsletten, L., Holmøy, T.

“…Moen SM, Celius EG, Nordsletten L, Holmøy T. Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis.
Acta…”
Get full text

Assessing vitamin D in the central nervous system by Holmøy, T., Moen, S. M.

“…Holmøy T, Moen SM. Assessing vitamin D in the central nervous system. Acta Neurol Scand: 2010: 122 (Suppl. 190): 88–92. © 2010 John Wiley & Sons A/S…”
Get full text

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore by Holmøy, T., Torkildsen, Ø., Myhr, K.-M., Løken-Amsrud, K. I.

“…Objectives Observational studies suggest that increasing the serum concentration of 25‐hydroxyvitamin D with 50 nm could halve the relapse risk in…”
Get full text

Intrathecal levels of vitamin D and IgG in multiple sclerosis by Holmøy, T., Lossius, A., Gundersen, T. E., Moen, S. M., Castellazzi, M., Fainardi, E., Casetta, I.

“…Holmøy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I. Intrathecal levels of vitamin D and IgG in multiple sclerosis. 
Acta Neurol…”
Get full text

Immunopathogenesis of multiple sclerosis: concepts and controversies by Holmoey, T

“…Hundred and fifty years after the discovery of multiple sclerosis (MS), neither the etiology nor the mechanism of disease is fully charted, and current…”
Get full text